KM
CVS icon

Kalos Management’s CVS Health CVS Stock Holding History

Kalos Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-70
Closed -$5.2K – 179
2023
Q1 		$5.2K Buy
+70
New +$5.87K 0.01% 272
2019
Q3 		– Sell
-21,966
Closed -$1.44M – 205
2019
Q2 		$1.44M Sell
21,966
-2,342
-10% -$126K 0.65% 41
2019
Q1 		$1.31M Buy
24,308
+1,823
+8% +$113K 0.85% 36
2018
Q4 		$1.47M Sell
22,485
-1,142
-5% -$85.2K 0.72% 41
2018
Q3 		$1.86M Sell
23,627
-659
-3% -$47.1K 1% 28
2018
Q2 		$1.57M Buy
24,286
+503
+2% +$33.1K 0.71% 43
2018
Q1 		$1.49M Buy
23,783
+1,480
+7% +$106K 0.88% 40
2017
Q4 		$1.61M Buy
22,303
+659
+3% +$47.9K 0.76% 40
2017
Q3 		$1.76M Buy
21,644
+1,821
+9% +$144K 1.13% 30
2017
Q2 		$1.59M Buy
19,823
+876
+5% +$69.2K 1.46% 23
2017
Q1 		$1.49M Buy
+18,947
New +$1.51M 1.05% 35
2016
Q2 		– Sell
-3,474
Closed -$360K – 159
2016
Q1 		$360K Buy
+3,474
New +$338K 0.3% 98
2015
Q4 		– Hold
0
– – – 275

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Kalos Management's CVS Position: Q2 2023 in Review

Kalos Management sold out of CVS Health (CVS) in Q2 2023, closing a stake of 70 shares — an estimated $5.2K sold.

Kalos Management first reported a position in CVS in Q1 2016 and held it in 12 quarters. The position peaked at $1.86M in Q3 2018. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • Kalos Management reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
  • Kalos Management sold 70 CVS Health shares in Q2 2023, an estimated $5.2K.
  • Kalos Management first reported a position in CVS Health in Q1 2016 and held it in 12 quarters.
  • Kalos Management's CVS Health position peaked at $1.86M in Q3 2018.
  • 2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Kalos Management's 13F filing for Q2 2023, filed 9 Aug 2023.